Benedict Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Sell
33,255
-29
-0.1% -$9.93K 2.34% 10
2026
Q1
$11.7M Sell
33,284
-377
-1% -$134K 2.44% 9
2025
Q4
$11M Buy
33,661
+24
+0.1% +$7.61K 2.32% 9
2025
Q3
$9.49M Buy
33,637
+275
+0.8% +$79.8K 2.06% 11
2025
Q2
$9.32M Buy
33,362
+263
+0.8% +$74.5K 2.11% 10
2025
Q1
$10.3M Buy
33,099
+558
+2% +$165K 2.39% 7
2024
Q4
$8.48M Buy
32,541
+263
+0.8% +$78K 2.06% 10
2024
Q3
$10.4M Sell
32,278
-167
-0.5% -$54.6K 2.46% 4
2024
Q2
$10.1M Sell
32,445
-421
-1% -$124K 2.57% 3
2024
Q1
$9.34M Sell
32,866
-148
-0.4% -$43.3K 2.37% 5
2023
Q4
$9.51M Buy
33,014
+192
+0.6% +$52.3K 2.59% 4
2023
Q3
$8.82M Buy
32,822
+255
+0.8% +$63.6K 2.55% 6
2023
Q2
$7.23M Buy
32,567
+609
+2% +$141K 1.99% 8
2023
Q1
$7.73M Buy
31,958
+495
+2% +$122K 2.18% 8
2022
Q4
$8.26M Sell
31,463
-313
-1% -$83.9K 2.45% 6
2022
Q3
$7.16M Buy
31,776
+124
+0.4% +$30.1K 2.29% 6
2022
Q2
$7.7M Buy
31,652
+550
+2% +$135K 2.28% 5
2022
Q1
$7.52M Buy
31,102
+647
+2% +$149K 2.01% 8
2021
Q4
$6.85M Buy
30,455
+926
+3% +$195K 1.79% 11
2021
Q3
$6.28M Buy
29,529
+807
+3% +$186K 1.75% 12
2021
Q2
$7M Buy
28,722
+507
+2% +$125K 1.94% 10
2021
Q1
$7.02M Buy
28,215
+334
+1% +$79.7K 2.03% 8
2020
Q4
$6.41M Buy
27,881
+497
+2% +$115K 2.31% 9
2020
Q3
$6.96M Buy
27,384
+522
+2% +$129K 2.68% 5
2020
Q2
$6.34M Buy
26,862
+64
+0.2% +$14.6K 2.61% 6
2020
Q1
$5.43M Buy
26,798
+215
+0.8% +$47K 2.56% 6
2019
Q4
$6.41M Buy
26,583
+249
+0.9% +$54.9K 2.5% 7
2019
Q3
$5.1M Buy
26,334
+319
+1% +$61.2K 2.09% 9
2019
Q2
$4.79M Buy
26,015
+857
+3% +$153K 2% 11
2019
Q1
$4.78M Buy
25,158
+621
+3% +$119K 2.07% 11
2018
Q4
$4.78M Buy
24,537
+274
+1% +$53.5K 2.36% 8
2018
Q3
$5.03M Buy
24,263
+262
+1% +$51.6K 2.25% 9
2018
Q2
$4.43M Buy
24,001
+573
+2% +$101K 2.19% 11
2018
Q1
$3.99M Buy
23,428
+211
+0.9% +$38.7K 2.01% 13
2017
Q4
$4.04M Buy
23,217
+357
+2% +$63.2K 1.94% 15
2017
Q3
$4.26M Buy
22,860
+137
+0.6% +$24.3K 2.19% 12
2017
Q2
$4.09M Buy
22,723
+377
+2% +$61.3K 2.13% 14
2017
Q1
$3.67M Buy
22,346
+764
+4% +$127K 1.99% 14
2016
Q4
$3.15M Buy
21,582
+1,228
+6% +$185K 1.82% 19
2016
Q3
$3.41M Buy
20,354
+1,296
+7% +$219K 1.99% 17
2016
Q2
$2.94M Buy
19,058
+1,113
+6% +$173K 1.72% 22
2016
Q1
$2.69M Buy
17,945
+224
+1% +$33.3K 1.64% 23
2015
Q4
$2.88M Buy
17,721
+399
+2% +$62.7K 1.83% 22
2015
Q3
$2.4M Sell
17,322
-156
-0.9% -$24.6K 1.66% 23
2015
Q2
$2.87M Sell
17,478
-112
-0.6% -$17.9K 1.87% 20
2015
Q1
$2.86M Buy
17,590
+260
+2% +$40.9K 1.84% 19
2014
Q4
$2.62M Buy
+17,330
New +$2.7M 1.72% 21

Other funds holding AMGN

Benedict Financial Advisors's AMGN Position: Q2 2026 in Review

Benedict Financial Advisors reduced its Amgen (AMGN) stake by 0.09% in Q2 2026, selling an estimated $9.93K and leaving 33,255 shares worth $12M. The position accounts for 2.34% of the portfolio, ranked #10.

Benedict Financial Advisors first reported a position in AMGN in Q4 2014 and has held it in 47 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Benedict Financial Advisors held 33,255 shares of Amgen worth $12M as of Q2 2026.
  • Benedict Financial Advisors sold 29 Amgen shares in Q2 2026, an estimated $9.93K.
  • Amgen made up 2.34% of Benedict Financial Advisors's portfolio in Q2 2026, its #10 holding.
  • Benedict Financial Advisors first reported a position in Amgen in Q4 2014 and has held it in 47 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Benedict Financial Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.